The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity.

Upon zabadinostat treatment, there was a highly significant increase in the size of the CD11c and CD86 DC populations, which coincided with increased H3K14 acetylation (Fig. 3a, b and Supplementary Fig. 6 ).

also in 132,142 other papers